Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04696328 |
|
Recruitment Status : Unknown
Verified April 2021 by Koichi Toda, Osaka University.
Recruitment status was: Recruiting
First Posted : January 6, 2021
Last Update Posted : April 20, 2021
|
Sponsor:
Osaka University
Collaborator:
Cuorips Inc.
Information provided by (Responsible Party):
Koichi Toda, Osaka University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | May 30, 2022 |
| Estimated Study Completion Date : | May 30, 2023 |